Taiko Pharmaceutical Co (TSE:4574) Additional Paid-In Capital : 円2,719 Mil(As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Additional Paid-In Capital?

Taiko Pharmaceutical Co's quarterly additional paid-in capital increased from Sep. 2023 (円2,626 Mil) to Dec. 2023 (円2,689 Mil) and increased from Dec. 2023 (円2,689 Mil) to Mar. 2024 (円2,719 Mil).

Taiko Pharmaceutical Co's annual additional paid-in capital increased from Mar. 2020 (円1,239 Mil) to Dec. 2021 (円1,648 Mil) but then declined from Dec. 2021 (円1,648 Mil) to Dec. 2022 (円1,642 Mil).

Taiko Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Taiko Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Additional Paid-In Capital Chart

Taiko Pharmaceutical Co Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

889.52

982.70

1,238.86

1,648.00

1,642.00

Taiko Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,659.00	2,340.00	2,626.00	2,689.00	2,719.00

Taiko Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Taiko Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiko Pharmaceutical Co (TSE:4574) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032

Website

http://www.seirogan.co.jp

Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co (TSE:4574) Headlines

No Headlines